RankingsPricing
  1. US-listed companies
  2. BOSTON SCIENTIFIC CORP
  3. Financials
  4. Diluted EPS

BOSTON SCIENTIFIC CORPBSX

Market cap
$143.3B
P/E ratio
SummaryFinancials
Period EndDiluted EPS (USD)YoY (%)
Dec 31, 20241.3+16.82%
Dec 31, 20231.1+137.78%
Dec 31, 20220.5-34.78%
Dec 31, 20210.7-962.50%
Dec 31, 2020-0.1-102.40%
Dec 31, 20193.3+179.83%
Dec 31, 20181.2+1387.50%
Dec 31, 20170.1-68.00%
Dec 31, 20160.3-238.89%
Dec 31, 2015-0.2+100.00%
Dec 31, 2014-0.1+0.00%
Dec 31, 2013-0.1-96.89%
Dec 31, 2012-2.9-1096.55%
Dec 31, 20110.3-141.43%
Dec 31, 2010-0.7

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating income Operating expenses Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSAdjusted EPSDividend payout ratio (%)Dividend per shareAdjusted DPSEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)